microRNA-18a is a genetic marker for the early diagnosis of cerebral injury induced by type 2 diabetes.

about

A Systematic Study of Dysregulated MicroRNA in Type 2 Diabetes Mellitus.

P2860

Q37728970-07CAAAB0-E381-4921-A159-3D8AD1F8FFED

P2860

microRNA-18a is a genetic marker for the early diagnosis of cerebral injury induced by type 2 diabetes.

Item

http://www.wikidata.org/entity/Q42973393

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

microRNA-18a is a genetic mark ...... ry induced by type 2 diabetes.

@en

microRNA-18a is a genetic mark ...... ry induced by type 2 diabetes.

@nl

type

Item

label

microRNA-18a is a genetic mark ...... ry induced by type 2 diabetes.

@en

microRNA-18a is a genetic mark ...... ry induced by type 2 diabetes.

@nl

prefLabel

microRNA-18a is a genetic mark ...... ry induced by type 2 diabetes.

@en

microRNA-18a is a genetic mark ...... ry induced by type 2 diabetes.

@nl

P1476

microRNA-18a is a genetic mark ...... ry induced by type 2 diabetes.

@en

P2093

Gang Mao

http://www.w3.org/2001/XMLSchema#string

Lei Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

Type-2 diabetes mellitus and auditory brainstem response.

N-acetylcysteine and allopurinol confer synergy in attenuating myocardial ischemia injury via restoring HIF-1α/HO-1 signaling in diabetic rats.

MicroRNA expression profile in human macrophages in response to Leishmania major infection

MicroRNA-26a inhibits angiogenesis by down-regulating VEGFA through the PIK3C2α/Akt/HIF-1α pathway in hepatocellular carcinoma.

Loss of p53 and acquisition of angiogenic microRNA profile are insufficient to facilitate progression of bladder urothelial carcinoma in situ to invasive carcinoma

Cerebral hemodynamics and systemic endothelial function are already impaired in well-controlled type 2 diabetic patients, with short-term disease.

Dysmyelination not demyelination causes neurological symptoms in preweaned mice in a murine model of Cockayne syndrome.

Wound outcome in combat injuries is associated with a unique set of protein biomarkers.

Hypoxia and HIF-1 increase S100A8 and S100A9 expression in prostate cancer.

P304

1901-1905

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/ETM.2014.1996

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267873708

http://www.w3.org/2001/XMLSchema#string

P698

25371752

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

microRNA

P932

4218637

http://www.w3.org/2001/XMLSchema#string

microRNA-18a is a genetic marker for the early diagnosis of cerebral injury induced by type 2 diabetes.

about

P2860

P2860

microRNA-18a is a genetic marker for the early diagnosis of cerebral injury induced by type 2 diabetes.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P5875

P698

P921

P932